Diagnosis of PML-IRIS should be considered in any HIV-infected patient developing unexplained neurological disorders or worsening of a previously diagnosed PML 2 weeks to 4 months after the initiation or resumption of effective cART, independently of the CD4 cell count prior to cART. The gene discussed is CD4; the disease is progressive multifocal leukoencephalopathy.